Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
22.64
-0.15 (-0.66%)
Nov 20, 2024, 4:00 PM EST - Market closed
Nurix Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is December - November.
Millions USD. Fiscal year is Dec - Nov.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Aug '24 Aug 31, 2024 | Nov '23 Nov 30, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 | Nov '20 Nov 30, 2020 | Nov '19 Nov 30, 2019 | 2018 |
| Net Income | -176.98 | -143.95 | -180.36 | -117.19 | -43.24 | -21.7 | Upgrade
|
| Depreciation & Amortization | 14.48 | 12.25 | 9.61 | 5.28 | 2.18 | 2.35 | Upgrade
|
| Other Amortization | 1.4 | 1.4 | 1.2 | 0.8 | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.01 | 0.56 | 0.01 | 0.13 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -9.76 | -5.42 | 0.43 | 1.71 | 0.27 | -0.11 | Upgrade
|
| Stock-Based Compensation | 33.45 | 33.67 | 28.13 | 15.8 | 4.3 | 0.51 | Upgrade
|
| Other Operating Activities | 0.29 | - | 0.2 | - | - | - | Upgrade
|
| Change in Accounts Receivable | 2 | - | 6 | -6 | -7.5 | - | Upgrade
|
| Change in Accounts Payable | 2.27 | 1.61 | 0.09 | 1.59 | 1.23 | 0.3 | Upgrade
|
| Change in Unearned Revenue | 35.58 | 19.51 | -26.63 | 14.25 | 48.18 | 16.89 | Upgrade
|
| Change in Income Taxes | - | - | - | 3.64 | -3.85 | - | Upgrade
|
| Change in Other Net Operating Assets | 0.12 | -1.01 | 1.52 | -4.37 | -1.66 | 2.36 | Upgrade
|
| Operating Cash Flow | -97.14 | -81.37 | -159.81 | -84.37 | -0.08 | 0.6 | Upgrade
|
| Capital Expenditures | -9.75 | -8.4 | -12.24 | -5.66 | -4.55 | -1.65 | Upgrade
|
| Investment in Securities | -121.52 | 76.7 | 39.44 | -102.59 | -249.85 | 10.15 | Upgrade
|
| Investing Cash Flow | -131.27 | 68.3 | 27.2 | -108.25 | -254.4 | 8.5 | Upgrade
|
| Issuance of Common Stock | 285.17 | 3.22 | 22.43 | 164.13 | 239.42 | 0.14 | Upgrade
|
| Other Financing Activities | -0.02 | - | 94.76 | -10.24 | -20.65 | -0.02 | Upgrade
|
| Financing Cash Flow | 285.15 | 3.22 | 117.19 | 153.88 | 339.02 | 0.13 | Upgrade
|
| Net Cash Flow | 56.74 | -9.85 | -15.42 | -38.73 | 84.54 | 9.23 | Upgrade
|
| Free Cash Flow | -106.9 | -89.77 | -172.05 | -90.03 | -4.63 | -1.05 | Upgrade
|
| Free Cash Flow Margin | -189.45% | -116.60% | -445.42% | -302.61% | -26.00% | -3.37% | Upgrade
|
| Free Cash Flow Per Share | -1.75 | -1.65 | -3.54 | -2.10 | -0.30 | -0.32 | Upgrade
|
| Cash Income Tax Paid | - | - | - | 0.48 | 0 | 0 | Upgrade
|
| Levered Free Cash Flow | -56.77 | -41.93 | -79.35 | -37.7 | -25.94 | -29.4 | Upgrade
|
| Unlevered Free Cash Flow | -56.77 | -41.93 | -79.35 | -37.7 | -25.94 | -29.4 | Upgrade
|
| Change in Net Working Capital | -24.72 | -16.06 | -8.8 | -19.76 | -12.75 | 16.71 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.